Dennis M. Brown - 13 Feb 2019 Form 4 Insider Report for Cell Source, Inc. (CLCS)

Role
Director
Signature
/s/ Dennis M. Brown
Issuer symbol
CLCS
Transactions as of
13 Feb 2019
Transactions value $
$58,966
Form type
4
Filing time
10 Jun 2021, 13:40:30 UTC
Next filing
07 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLCS Common Stock Other $4,450 +5,934 +5.9% $0.75 105,934 31 Dec 2019 Direct F1
transaction CLCS Common Stock Other $2,244 +2,992 +2.8% $0.75 108,926 30 Jun 2020 Direct F1
transaction CLCS Common Stock Other $2,268 +3,025 +2.8% $0.75 111,951 29 Dec 2020 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLCS Series A Convertible Preferred Stock Award $50,002 +6,667 $7.5* 6,667 13 Feb 2019 Common Stock 66,670 $0.75 Direct F2
transaction CLCS Director Stock Option (Right to Buy) Award $0 +450,000 $0 450,000 19 Aug 2020 Common Stock 450,000 $0.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued as payment-in-kind dividend on Series A Convertible Preferred Stock.
F2 The Series A Convertible Preferred Stock has no expiration date.